INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹193 Cr | ₹342 Cr | ₹389 Cr | ₹349 Cr | ₹216 Cr |
What is the latest Net Current Assets ratio of INDOCO REMEDIES ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹193 Cr |
| Mar2024 | ₹342 Cr |
| Mar2023 | ₹389 Cr |
| Mar2022 | ₹349 Cr |
| Mar2021 | ₹216 Cr |
How is Net Current Assets of INDOCO REMEDIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹193 Cr | -43.52 | |
| Mar2024 | ₹342 Cr | -12.01 | |
| Mar2023 | ₹389 Cr | 11.55 | |
| Mar2022 | ₹349 Cr | 61.76 | |
| Mar2021 | ₹216 Cr | - | |
Compare Net Current Assets of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,026.4 Cr | -11.4% | -9.8% | -32.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 0.8% | 6.3% | 18.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.6% | 20.7% | 18.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | 1.7% | 9.4% | 38.5% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 4.5% | 1.2% | -1.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.3% | -14.8% | -9.5% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -11.4% |
-9.8% |
-32.6% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses